For the most current list of clinical trials, see clinicaltrials.gov for trials in:
CurePSP is currently in partnership on the following clinical trials:
For more information contact the AbbVie Call Center at +1 847-283-8955 or click here.
Biogen is now recruiting for PASSPORT, a placebo-controlled clinical trial to evaluate the effectiveness and safety of an intravenously administered investigational study drug in participants with PSP.
For more information contact the Biogen Call Center at +1 866-633-4636 or click here.
Clinical Research Studies
The Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) consortium is dedicated to conducting clinical research in PSP, CBD, and related diseases. There are currently 14 clinical study sites in the United States and Canada. To learn more about this study, please click here.
The 4 Repeat Tauopathy Neuroimaging Initiative. The goal of this study is to identify the most reliable methods of analysis for tracking CBD and PSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood, urine and cerebrospinal fluid (CSF) ‟biomarkers.” To learn more about this study, please click here.
The FTD Disorders Registry
The Registry is an online database to collect information from those affected by all types of prime of life brain diseases, such as PSP, CBD, and related. Persons diagnosed, (current/former) caregivers, family, and friends can join. As a member of the Registry, you can help us advance the science and move faster toward finding treatments and cures. Join the registry here.